Condition
Fracture
ClinicalTrials.gov condition label
Clinical trials
14 shownClinical and Radiological Outcomes of Medacta Shoulder System FRNCT05926622 · 2022-03-15
RECRUITINGExactech Shoulder Post Market Clinical Follow-up StudyNCT05603728 · 2007-07-19
RECRUITINGImmediate Fracture Risk After Antihypertensive Drug InitiationNCT06964217 · 2025-06-01
NOT_YET_RECRUITINGLinkSymphoKnee (LSK) Total Knee Replacement System Study - Ultra-congruent (UC)NCT06670651 · 2025-03-21
ENROLLING_BY_INVITATIONClinical and Radiological Outcomes of Medacta Shoulder System (BE)NCT05002335 · 2020-10-06
ACTIVE_NOT_RECRUITINGWright Foot & Ankle Post-Market Observational StudyNCT04118894 · 2020-01-22
TERMINATEDClinical and Radiological Outcomes of Medacta Shoulder SystemNCT03547947 · 2018-06-13
ACTIVE_NOT_RECRUITINGClinical Evaluation of the TITAN™ Total Shoulder SystemNCT03245320 · 2017-03-20
TERMINATEDArcos Revision Stem: Evaluation of Clinical PerformanceNCT01820611 · 2013-02-01
COMPLETEDPolymorphisms in the Vitamin D System and HealthNCT01395303 · 2011-04-01
COMPLETEDMulti Centre Study on TESS V2 Shoulder SystemNCT03431857 · 2010-10-20
COMPLETEDBone to Skin Thickness Study: Obese Versus Normal PopulationNCT01248182 · 2010-09-01
TERMINATEDDo Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?NCT00766532 · 2009-01-01
COMPLETEDFractures Stratified by HIV and Antiretroviral Therapy (ART) StatusNCT01077557 · 2006-11-01
COMPLETEDCommon interventions
Medacta Shoulder SystemDEVICE2Any Antiretroviral (ARV) Drug ExposureDRUG1Arcos Revision Stem SystemDEVICE1Aromatase InhibitorDRUG1Combination therapyDRUG1Foot and Ankle DevicesDEVICE1Integra TITAN™ Total Shoulder Generation 1.0DEVICE1MonotherapyDRUG1No Antiretroviral (ARV) Drug ExposureOTHER1TESS V2DEVICE1total knee arthroplasty deviceDEVICE1
Leading sponsors
Trial status mix
COMPLETED5
TERMINATED3
ACTIVE_NOT_RECRUITING2
RECRUITING2
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1
Phase mix
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.